Get the Stockscreener App
2.78
0.00%
0.00
After Hours:
2.77
-0.010
-0.36%
Soligenix Inc stock is traded at $2.78, with a volume of 136.21K.
It is up +0.00% in the last 24 hours and up +13.93% over the past month.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
See More
Previous Close:
$2.78
Open:
$2.78
24h Volume:
136.21K
Relative Volume:
0.01
Market Cap:
$11.91M
Revenue:
$960.60K
Net Income/Loss:
$-7.10M
P/E Ratio:
-0.3677
EPS:
-7.56
Net Cash Flow:
$-8.00M
1W Performance:
-8.55%
1M Performance:
+13.93%
6M Performance:
+23.17%
1Y Performance:
-19.19%
1-Day Range:
$2.73
$2.90
1-Week Range:
$2.575
$3.07
52-Week Range:
$1.09
$6.2299
Soligenix Inc Stock (SNGX) Company Profile
Name
Soligenix Inc
Sector
Industry
Phone
609-538-8200
Address
29 EMMONS DRIVE, PRINCETON
Compare SNGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNGX
Soligenix Inc
|
2.78 | 11.91M | 960.60K | -7.10M | -8.00M | -7.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.37 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
468.58 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
568.20 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
763.52 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
335.67 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Soligenix Inc Stock (SNGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-20 | Downgrade | Dawson James | Buy → Neutral |
| Jan-31-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Aug-14-17 | Reiterated | Maxim Group | Buy |
| Jul-17-17 | Initiated | H.C. Wainwright | Buy |
Soligenix Inc Stock (SNGX) Latest News
Soligenix (NASDAQ: SNGX) Showcases Expanding Rare Disease, Public Health Pipeline in Latest Corporate Presentation - The Globe and Mail
Soligenix Expands Rare Disease and Public Health Pipeline in New Corporate Presentation - citybuzz -
What’s the analyst consensus on Soligenix Inc.2025 Dividend Review & Low Drawdown Trading Strategies - beatles.ru
Tick level data insight on Soligenix Inc. volatilityPortfolio Return Report & Real-Time Market Sentiment Alerts - Newser
Top chart patterns to watch in Soligenix Inc.July 2025 Closing Moves & Free High Return Stock Watch Alerts - Newser
Identifying reversal signals in Soligenix Inc.Forecast Cut & Free Growth Oriented Trading Recommendations - Newser
What data driven models say about Soligenix Inc.’s futureMarket Sentiment Summary & Smart Investment Allocation Tips - Newser
Aug Catalysts: Is Soligenix Inc.’s ROE strong enough2025 Technical Overview & Daily Volume Surge Trade Alerts - خودرو بانک
Best data tools to analyze Soligenix Inc. stockJuly 2025 Trends & Momentum Based Trading Ideas - Newser
What is Soligenix Inc. s debt to equity ratio2025 Short Interest & Real-Time Price Movement Reports - خودرو بانک
Soligenix (NASDAQ: SNGX) Publishes Data Demonstrating Two-Year Stability of ThermoVax Ebolavirus Vaccines - Barchart.com
Can Soligenix Inc. reach all time highs this year2025 Major Catalysts & Technical Pattern Recognition Alerts - خودرو بانک
Order flow analysis tools used on Soligenix Inc.2025 Year in Review & Consistent Profit Focused Trading Strategies - Newser
Soligenix Inc. (NASDAQ: SNGX) Proprietary Platform Aims to Meet Growing Need for Effective CTCL Therapy - ADVFN Brasil
Signal strength of Soligenix Inc. stock in tech scannersQuarterly Portfolio Report & Long-Term Safe Return Strategies - Newser
Published on: 2025-09-05 06:31:37 - Newser
How cyclical is Soligenix Inc.’s revenue streamJuly 2025 PostEarnings & Real-Time Chart Pattern Alerts - خودرو بانک
Soligenix shares fall 5.59% premarket after announcing long-term stability of ebolavirus vaccines. - AInvest
Funding News and AnnouncementsGrantNews - GrantWatch
Why Soligenix Inc. stock attracts strong analyst attentionJuly 2025 Update & Daily Price Action Insights - Newser
Soligenix Tumbles After Company Publishes Paper - Baystreet.ca
How do insiders feel about Soligenix Inc.Earnings Growth Report & Stepwise Trade Signal Guides - خودرو بانک
Risk adjusted return profile for Soligenix Inc. analyzedTrade Performance Summary & Smart Swing Trading Techniques - Newser
FDA Grants Orphan Drug Designation to Soligenix's Dusquetide for Behçet's Disease Treatment - citybuzz -
Analyzing Soligenix Inc. with multi timeframe charts2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
Can volume confirm reversal in Soligenix Inc.Treasury Yields & Smart Investment Allocation Insights - Newser
Soligenix Announces Two-Year Stability for ThermoVax Ebolavirus Vaccines at Elevated Temperatures - citybuzz -
Soligenix’s ThermoVax platform shows efficacy in vaccine stability - TipRanks
Soligenix, Inc. Announces Publication Recommending Long-Term High Temperature Stability of Protein Subunit Vaccines forbola and Related Viruses - MarketScreener
Soligenix’s Thermostable Vaccine Breakthrough: Reshaping Global Immunization and Biopharma Scalability - AInvest
Soligenix announces publication describing long-term high temperature stability of protein subunit vaccines for Ebola and related viruses - MarketScreener
Soligenix Announces Publication Describing Long-Term High Temperature Stability of Protein Subunit Vaccines for Ebola and Related Viruses - The Malaysian Reserve
Soligenix reports two-year stability for filovirus vaccines at high temps - Investing.com
Does Soligenix Inc. fit your quant trading modelPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - Newser
Real time scanner hits for Soligenix Inc. explainedVolume Spike & Verified Chart Pattern Signals - Newser
How to build a custom watchlist for Soligenix Inc.Earnings Risk Summary & AI Forecast for Swing Trade Picks - Newser
Will Soligenix Inc. outperform its industry peers2025 Trading Volume Trends & Trade Opportunity Analysis Reports - خودرو بانک
Soligenix (NASDAQ: SNGX) CEO to Present at H.C. Wainwright Global Investment Conference - Barchart.com
Soligenix Invited to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Eastern Progress
What’s the recovery path for long term holders of Soligenix Inc.Weekly Trend Report & Capital Efficiency Focused Strategies - Newser
What technical models suggest about Soligenix Inc.’s comebackJuly 2025 Fed Impact & Community Verified Trade Signals - Newser
How high can Soligenix Inc. stock goPortfolio Value Summary & Verified Swing Trading Watchlist - Newser
What candlestick patterns are forming on Soligenix Inc.Weekly Stock Analysis & Community Verified Trade Signals - Newser
Technical analysis overview for Soligenix Inc. stockJuly 2025 Technicals & Community Trade Idea Sharing Platform - Newser
What’s next for Soligenix Inc. stock priceWeekly Trend Report & Safe Entry Point Identification - Newser
News impact scoring models applied to Soligenix Inc.2025 Valuation Update & Stepwise Entry and Exit Trade Signals - Newser
Quantitative breakdown of Soligenix Inc. recent moveTrade Risk Summary & Technical Pattern Alert System - Newser
Is Soligenix Inc. a turnaround storyJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - خودرو بانک
Soligenix CEO to Present at H.C. Wainwright Global Investment Conference - citybuzz -
Real time breakdown of Soligenix Inc. stock performance2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
What is the long term forecast for Soligenix Inc. stockInsider Selling & Verified Short-Term Trading Plans - خودرو بانک
Soligenix Inc Stock (SNGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):